Carlo Alviggi earned his MD degree in 1994, from the Faculty of Medicine of the University of Naples “Federico II” in Naples, Italy; he specialized in obstetrics and gynaecology in 1998, and gained a PhD in 2001, from the same university. During his career, he collaborated with: The Imperial College of London, in London, UK; the Laboratory of Immunology of the Italian National Research Council in Naples; and the Autoimmunity and Tolerance Laboratory of the University of California in Los Angeles, CA, USA. This network resulted in various publications, some of which concern new hypotheses on the pathogenesis of pelvic endometriosis. He is now an associate professor in reproductive medicine at the Fertility Unit of the University of Naples “Federico II”. Professor Alviggi’s current research interests are the role of luteinizing hormone (LH) in folliculogenesis; the use of LH-containing drugs in patients undergoing ovarian controlled stimulation for IVF; the pathogenesis of pelvic endometriosis; oncofertility; reproductive endocrinology; and the genetics of human reproduction. He has participated in several national and international (phase 2 and 3) multicentric, prospective randomized trials. Professor Alviggi has published extensively (over 100 publications indexed in Scopus) and has been invited to lecture at over 300 international meetings dealing with reproductive medicine and gynaecological endocrinology; he has also served as an ad hoc reviewer and editor for international journals in these fields. He is co-founder and coordinator of POSEIDON Group (Patient Oriented Strategies Encompassing Individualized Oocyte Number) created in 2015, envisaging discussing and elaborating practical solutions about the diagnosis and management of Low Prognosis Patients undergoing Assisted Reproductive Technology. Since 2020 he is vice president of SIFES (Società Italiana di Fertilità e Sterilità e Medicina della Riproduzione) and member of special interest group on infertility (GISS) of SIGO (Società Italiana di Ginecologia Ostetricia)
This site is intended for healthcare professionals
